Age | |
---|---|
51.2 (mean) | |
10–89 (range) | |
Gender | |
Male | 59 (55%) |
Female | 49 (45%) |
Site of PCR | |
Aqueous Tap | 65 (60.2%) |
Vitreous Tap | 43 (39.8%) |
Presenting Visual Acuity (logMAR) | |
Range | 0.00–3 |
Median | 1.2 |
According to anatomical site | |
Anterior uveitis | 28 (25.9%) |
Intermediate uveitis | 2 (2%) |
Posterior uveitis | 16 (14.8%) |
Panuveitis | 45 (41.7%) |
Anterior + intermediate uveitis | 4 (3.7%) |
According to duration | |
Acute uveitis | 48 (44.4%) |
Chronic uveitis | 55 (51%) |
Recurrent uveitis | 5 (4.6%) |
Pre-sampling diagnosis | |
Pre-sampling diagnosis not related to PCR | 19 (17.6%) |
Pre-sampling diagnosis related to PCR | 28 (26%) |
Unknown | 61 (56%) |
Initial Treatment | |
Immunosupression | 22 (20%) |
Antivirals | 45 (41.7%) |
Antibiotics and/or Antifungals | 30 (27.8%) |
Vitrectomy | 14 (13%) |
Topical agents | 69 (63.9%) |